VIXTIMOTAMAB
UNII 56FUB33G5M

Substance Identification & Data

This profile provides standardized clinical and technical data for Vixtimotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 56FUB33G5M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2243775-32-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

56FUB33G5M

CAS Registry Number

2243775-32-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIXTIMOTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C135632

National Cancer Institute reference terminology for clinical and research data.

INN ID

11475

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vixtimotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIXTIMOTAMAB

Common Names & Synonyms

AMV 564 [WHO-DD]

MABFRAG HUMAN (FAB) ANTI P20138 (CD33_HUMAN)MABFRAG HUMAN (FAB) ANTI P07766 (CD3_HUMAN) (AMV564)

MMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAIN VARIABLE FRAGMENT VH2-LINKER2-VL2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 HEAVY CHAIN VH1)

VIXTIMOTAMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAIN VARIABLE FRAGMENT VH2-LINKER2-VL2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 HEAVY CHAIN VH1)

SYS